ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

HEALTH-Retreat on Depo-Provera

HEALTH Retreat on Depo-Provera? Padma Prakash DEPO-PROVERA is an injectable contraceptive which has been on the verge of entry into the family planning programme and the drug market in India for some time now. Although it is licensed for use in 80 countries (most of them in the third world) the US Food and Drug Administration, the licensing authority in that country, has repeatedly held back its approval. Last month a Board of Inquiry convened by the FDA in 1983 came to the conclusion that there just was not sufficient evidence to prove that the drug was safe for long-term contraceptive use. Feminists and consumer groups in the US who have long campaigned for a ban on the drug have welcomed the decision. In the coming months the FDA will take the final decision which will affect millions of women not only in America, but all over the world.

To read the full text Login

Get instant access

New 3 Month Subscription
to Digital Archives at

₹826for India

$50for overseas users


(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top